TRCT
MIRO

Tower Research Capital (TRC)’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Tower Research Capital (TRC)’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,388
Closed -$7.06K – 6302
2023
Q3 		$7.06K Buy
5,388
+2,052
+62% +$2.99K ﹤0.01% 4513
2023
Q2 		$5.84K Buy
3,336
+2,038
+157% +$2.69K ﹤0.01% 4783
2023
Q1 		$2K Sell
1,298
-7,726
-86% -$20.1K ﹤0.01% 5440
2022
Q4 		$27K Buy
9,024
+5,412
+150% +$21.2K ﹤0.01% 2862
2022
Q3 		$16K Buy
+3,612
New +$11.7K ﹤0.01% 4148
2022
Q2 		– Sell
-1,288
Closed -$5K – 6738
2022
Q1 		$5K Sell
1,288
-1,297
-50% -$4.83K ﹤0.01% 5141
2021
Q4 		$12K Buy
2,585
+1,276
+97% +$9.06K ﹤0.01% 4353
2021
Q3 		$9K Buy
+1,309
New +$12.3K ﹤0.01% 4487

Tower Research Capital (TRC)'s MIRO Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 5,388 shares — an estimated $7.06K sold.

Tower Research Capital (TRC) first reported a position in MIRO in Q3 2021 and held it in 8 quarters. The position peaked at $27K in Q4 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,388 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $7.06K.
  • Tower Research Capital (TRC) first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Miromatrix Medical Inc. Common Stock position peaked at $27K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.